MRK
Merck
October 29, 2026 · market open
- Rarity
- 1.57
- Peak move
- +5.62%
- Float cap
- $348.4B
Still running — rarity and peak move can only rise from here.
Merck is a research-intensive biopharmaceutical company that discovers, develops and markets prescription medicines, biologic therapies and vaccines, with its largest franchise in oncology led by Keytruda, alongside cardiometabolic, respiratory, infectious disease and diabetes products. It sells to drug wholesalers, retailers, hospitals, government agencies and managed care providers. A separate animal health business supplies veterinary pharmaceuticals and vaccines to veterinarians, distributors and livestock producers.
Where do you see this going?
no votes yetVote to see the split.
What we found
no events · 0 from SEC or newswire · 0 timed with the moveNothing found.We searched SEC filings, the newswires and the open web across the three days around this move and found no public information that explains it.